Solstad Maritime Q3 2026 slides: record EBITDA, higher guidance

Solstad Maritime reported record Q3 2026 adjusted EBITDA of $117 million, up 68% year over year, as fleet utilization rose to 88%; it raised and narrowed full-year guidance to $375–390 million from $360–390 million. Firm backlog reached $1.086 billion, adjusted net debt fell to $488 million, and the company declared a $0.12-per-share dividend totaling about $56 million. Shares rose 5.39% to $29.35 after the presentation; management expects Q4 earnings to decline from the record quarter and cautioned that vessel supply could pressure North Sea utilization and day rates.

Analysis

The key asymmetry is between contracted earnings and marginal vessel pricing. Firm coverage dampens near-term revenue volatility, but it does not protect renewal economics: incoming CSV capacity and vessels relocating into the North Sea could pressure day rates when contracts roll. The three-vessel AHTS spot/project exposure is a limited share of fleet capacity, yet it is likely the most sensitive part of earnings to a reversal in spot conditions. Watch utilization and realized rates there, not just consolidated EBITDA.

Near term (days to weeks), the expected Q4 step-down and the November 6 ex-date make the post-results rally a poor reason to chase. The dividend is not a free return; the price may adjust mechanically, while the earnings path is seasonally less favorable. Over 1–3 months, contract conversion and North Sea winter utilization will matter more than the headline backlog. Over 6–18 months, newbuild deliveries and renewals determine whether today’s high backlog margins translate into durable cash generation.

Contrarian framing: the record quarter may be a peak-rate snapshot, but a seasonal decline alone would not invalidate the equity case if contracted coverage and leverage continue to improve. Conversely, backlog is not equivalent to cash flow: execution, maintenance and renewal pricing remain important. Without valuation and peer data, the evidence supports conditional exposure rather than an outright short or an aggressive add.

Key Decisions for Investors

• Do not chase SOMA after the sharp post-results move; consider initiating or adding only on weakness after the ex-date, provided management maintains 2026 EBITDA guidance of $375–390 million and contract coverage remains intact. No price target is supportable from the supplied data.
• Treat the November 6 ex-date as a timing event, not a dividend-capture trade. Reassess the position after the distribution and Q4 trading update rather than assuming the quarterly payout is assured at this level.
• Set an alert for evidence of supply-led deterioration: North Sea AHTS utilization or day rates weakening, book-to-bill falling below 1x, or a cut to the 2026 EBITDA range. Those would challenge the thesis more than a seasonal Q4 earnings decline alone.
• Avoid an outright short solely on expected Q4 seasonality. The thesis is falsified on the upside if utilization and realized rates hold through winter while backlog renewals preserve economics; review valuation and peer data before sizing a directional position.